BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23747719)

  • 1. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.
    Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L
    Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells.
    Hu Z; Du J; Yang L; Zhu Y; Yang Y; Zheng D; Someya A; Gu L; Lu X
    PLoS One; 2012; 7(6):e38777. PubMed ID: 22701712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.
    Morishige M; Hashimoto S; Ogawa E; Toda Y; Kotani H; Hirose M; Wei S; Hashimoto A; Yamada A; Yano H; Mazaki Y; Kodama H; Nio Y; Manabe T; Wada H; Kobayashi H; Sabe H
    Nat Cell Biol; 2008 Jan; 10(1):85-92. PubMed ID: 18084281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.
    Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E
    Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.
    Sabe H; Hashimoto S; Morishige M; Ogawa E; Hashimoto A; Nam JM; Miura K; Yano H; Onodera Y
    Traffic; 2009 Aug; 10(8):982-93. PubMed ID: 19416474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.
    Hashimoto A; Hashimoto S; Ando R; Noda K; Ogawa E; Kotani H; Hirose M; Menju T; Morishige M; Manabe T; Toda Y; Ishida S; Sabe H
    PLoS One; 2011; 6(8):e23359. PubMed ID: 21858086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process.
    Someya A; Moss J; Nagaoka I
    J Biol Chem; 2010 Oct; 285(40):30698-707. PubMed ID: 20601426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
    Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
    Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.
    Oka S; Uramoto H; Shimokawa H; Yamada S; Tanaka F
    Oncology; 2014; 86(5-6):263-70. PubMed ID: 24902879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
    Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L
    Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
    Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
    Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.
    Yoon SY; Lee YJ; Seo JH; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cell Res; 2006 Jan; 16(1):75-81. PubMed ID: 16467878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
    Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS
    J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting invasive with GEP100 and Arf6.
    Valderrama F; Ridley AJ
    Nat Cell Biol; 2008 Jan; 10(1):16-8. PubMed ID: 18172429
    [No Abstract]   [Full Text] [Related]  

  • 17. ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway.
    Tague SE; Muralidharan V; D'Souza-Schorey C
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9671-6. PubMed ID: 15210957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
    Marchesin V; Montagnac G; Chavrier P
    PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.
    Li M; Ng SS; Wang J; Lai L; Leung SY; Franco M; Peng Y; He ML; Kung HF; Lin MC
    Cancer Res; 2006 Feb; 66(3):1583-90. PubMed ID: 16452216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
    Raghu H; Sodadasu PK; Malla RR; Gondi CS; Estes N; Rao JS
    BMC Cancer; 2010 Nov; 10():647. PubMed ID: 21106094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.